Patent details

Basic Information

Publication number:

EP1767206

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Revoked

Application number:

EP061268199

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Solid oral dosage forms comprising valsartan and hydrochlorothiazide

French Title of Invention:

Formes orales solides comprenant du valsartan et de l'hydrochlorothiazide

German Title of Invention:

Feste orale Dosierungsformen enthaltend Valsartan und Hydrochlorothiazide

SPC Number:

Dates

Filing date:

18/06/1997

Grant date:

28/10/2009

EP Publication Date:

28/10/2009

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

28/03/2007

EP B1 Publication Date:

28/10/2009

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

18/06/2017

Renunciation date:

Revocation date:

01/04/2014

Annulment date:

Owner

From:

18/06/1997

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4002 Basel, Switzerland (CH)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

09/12/2009

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

Wagner Robert Frank

Address:

United States (US)

2

Name:

Yamato Fujiki

Address:

Japan (JP)

3

Name:

Taike Takashi

Address:

Japan (JP)

4

Name:

Katakuse Yoshimitsu

Address:

Japan (JP)

5

Name:

Kohlmeyer Manfred

Address:

Switzerland (CH)

Priority

Priority Number:

9613470

Priority Date:

27/06/1996

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

A61K 31/41;

Filing date	Document type	Number of pages